by Michael D. Martin (Author)

In the not-too-distant future, the pharmaceutical colossus Pharma has created the Longevity Line of treatments. Lifespan has been significantly lengthened. Cancer though, is still the nemesis of human life.
But now Pharma has created the Holy Grail for curing cancer, The Cure. Production of The Cure, however, is staggeringly dangerous. A single misstep would mean the end of human life on Earth. The production facility must be in an inaccessible location. Pharma chose Phobos, the larger moon of Mars, and placed the production laboratory, The Station, on it. Where no one else could or would go.
The first production crew includes Janie and Teddy, two individuals who are Neuroalt. What used to be called Neurodivergent. Janie has Trisomy 21, Down Syndrome, and Teddy is autistic. They are teenage children of crew.
A lab error leads to unthinkable disaster on the Station. Janie and Teddy must survive on Phobos even as Pharma tries to erase any evidence of the problem.
In this story, Neuroalt people are found to be creative and persistent problem solvers who can make impossible decisions in the face of terrible danger.

Guaranteed safe checkout: